Susan E. Knight - Jan 24, 2025 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John D. Manders, on behalf of Susan E. Knight
Stock symbol
SRDX
Transactions as of
Jan 24, 2025
Transactions value $
-$25
Form type
4
Date filed
1/28/2025, 05:39 PM
Previous filing
Feb 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $201K +7.36K +20.93% $27.30 42.5K Jan 24, 2025 Direct F1
transaction SRDX Common Stock Tax liability -$201K -5.27K -12.39% $38.15 37.2K Jan 24, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Options Exercise $0 -7.36K -100% $0.00 0 Jan 24, 2025 Common Stock 7.36K $27.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 17,286 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 Fully vested.